GSK plc reported that its executives increased their shareholdings by reinvesting dividends from April 9, 2026. On April 14, 2026, transactions included 1,178 Ordinary Shares at £21.67 each and 308 American Depositary Shares at $58.36 each, conducted on respective exchanges.